JENNISON ASSOCIATES LLC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 323 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.

Quarter-by-quarter ownership
JENNISON ASSOCIATES LLC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$134,745,629
-24.9%
3,542,209
+79.8%
0.11%
-22.4%
Q2 2023$179,521,932
+4.2%
1,970,603
-24.6%
0.15%
-7.0%
Q1 2023$172,338,112
+32.5%
2,612,767
+3.9%
0.16%
+19.7%
Q4 2022$130,067,043
-24.9%
2,515,317
-0.8%
0.13%
-23.3%
Q3 2022$173,121,000
+66.6%
2,534,712
+10.3%
0.17%
+65.4%
Q2 2022$103,931,000
-24.4%
2,298,347
-15.0%
0.10%
+3.0%
Q1 2022$137,410,000
+56.1%
2,704,390
+45.2%
0.10%
+80.4%
Q4 2021$88,043,000
+28.5%
1,862,157
-10.4%
0.06%
+27.3%
Q3 2021$68,519,000
-55.7%
2,078,845
-15.1%
0.04%
-57.3%
Q2 2021$154,810,000
+33.1%
2,449,524
-9.6%
0.10%
+21.2%
Q1 2021$116,324,000
-26.6%
2,710,877
-2.2%
0.08%
-24.8%
Q4 2020$158,582,000
+85.2%
2,772,420
-2.3%
0.11%
+63.8%
Q3 2020$85,616,000
+23.2%
2,837,786
+33.4%
0.07%
+9.5%
Q2 2020$69,470,000
+24.1%
2,127,078
+1.8%
0.06%
-7.4%
Q1 2020$55,978,000
+65.4%
2,089,517
+89.1%
0.07%
+100.0%
Q4 2019$33,836,000
+27.9%
1,105,031
+0.6%
0.03%
+21.4%
Q3 2019$26,459,000
+13.1%
1,098,355
+19.0%
0.03%
+21.7%
Q2 2019$23,395,000
+104.3%
923,244
+57.2%
0.02%
+109.1%
Q1 2019$11,454,000
+47.9%
587,381
+0.1%
0.01%
+22.2%
Q4 2018$7,742,000
-24.3%
586,924
+2.1%
0.01%0.0%
Q3 2018$10,221,000
-18.6%
574,859
+0.8%
0.01%
-25.0%
Q2 2018$12,550,000
+49.7%
570,464
+50.5%
0.01%
+50.0%
Q1 2018$8,383,000
-36.3%
379,151
-37.5%
0.01%
-38.5%
Q4 2017$13,170,000606,9250.01%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 2,503,059$170,959,00029.50%
ACUTA CAPITAL PARTNERS, LLC 554,000$37,838,00016.29%
Avoro Capital Advisors LLC 10,125,000$691,538,00012.78%
Sio Capital Management, LLC 507,700$34,676,00011.02%
Logos Global Management LP 1,300,000$88,790,00010.92%
EcoR1 Capital, LLC 5,183,431$354,028,00010.45%
Cormorant Asset Management, LP 1,478,000$100,947,0007.06%
Finepoint Capital LP 266,090$18,174,0005.98%
Ghost Tree Capital, LLC 275,000$18,783,0005.27%
Boxer Capital, LLC 1,303,700$89,043,0005.01%
View complete list of APELLIS PHARMACEUTICALS INC shareholders